|
|
Volumn 15, Issue 2, 2009, Pages 238-243
|
|
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis
a,r
|
|
Author keywords
Glatiramer acetate; MRI; Multiple sclerosis; Protiramer; TV 5010
|
|
Indexed keywords
COPOLYMER;
GADOLINIUM;
IMMUNOMODULATING AGENT;
PROTIRAMER;
TV 5010;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
BRAIN DAMAGE;
CLINICAL TRIAL;
CONTRAST ENHANCEMENT;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSPNEA;
EXPANDED DISABILITY STATUS SCALE;
FEMALE;
HEART PALPITATION;
HUMAN;
HYPERSENSITIVITY REACTION;
IDIOPATHIC THROMBOCYTOPENIC PURPURA;
INJECTION SITE ERYTHEMA;
INJECTION SITE INDURATION;
INJECTION SITE PAIN;
INJECTION SITE REACTION;
MAJOR CLINICAL STUDY;
MALE;
MOLECULAR WEIGHT;
MULTICENTER STUDY;
MULTIPLE SCLEROSIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OPEN STUDY;
PARALLEL DESIGN;
PILOT STUDY;
PNEUMOTHORAX;
RISK REDUCTION;
SEIZURE;
SIDE EFFECT;
SKIN NECROSIS;
TACHYCARDIA;
THORAX PAIN;
VASODILATATION;
ADULT;
CHEMISTRY, PHARMACEUTICAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INJECTIONS, SUBCUTANEOUS;
MALE;
MOLECULAR WEIGHT;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
PEPTIDES;
PILOT PROJECTS;
TREATMENT OUTCOME;
|
|
EID: 59349105358
PISSN: 13524585
EISSN: None
Source Type: Journal
DOI: 10.1177/1352458508098269 Document Type: Article |
|
Times cited : (17)
|
|
References (9)
|
